Nathan Wong/LinkedIn
Mar 27, 2026, 16:23
Nathan Wong: Lp(a) Testing as a Class I Recommendation in 2026 Guidelines
Nathan Wong, Professor and Director of the Heart Disease Prevention Program, Division of Cardiology at UC Irvine, shared a post on LinkedIn:
“Today is Lp(a) Awareness Day and testing it at least once in all adults is now a Class I recommendation from the new 2026 ACC/AHA/Multisociety Dyslipidemia Guideline and there’s a lot we can do to lower risk in those with elevated levels.”
American College of Cardiology shared a post on LinkedIn:
“Learn about the unique role of Lp (a) as a genetic determinant for ASCVD risk and the importance of testing for Lp (a) levels to better understand your patients’ cardiovascular health with ACC’s online course.”
Stay updated with Hemostasis Today.
-
Nov 8, 2026, 12:22Marc Carrier: Advancing Catheter-Related Thrombosis Prevention Through Factor XI Inhibition
-
Nov 8, 2026, 11:56Why Genetic Predisposition Does Not Always Lead to Thrombosis – Stork Genetics
-
Nov 8, 2026, 11:45Sher-Lu Pai: Investigating Intracardiac Thrombosis and Its Management in Liver Transplantation
-
Nov 8, 2026, 11:25Mehmet Cilingiroglu: Navigating Anticoagulation Choices in Acute Coronary Syndrome PCI
-
Nov 8, 2026, 07:16Gilberto de lima Lopes Junior: The Cardiovascular Consequences of Cancer in Younger Patients
-
Nov 8, 2026, 06:51Haney Mallemat: Key Principles and Pitfalls of LVAD Emergencies
-
Nov 8, 2026, 06:31Maria Omer: Clinical Recognition and Management of Cavernous Sinus Thrombosis
-
Nov 8, 2026, 06:16Natasha Jolakoski: University of New Mexico Hospital Promotes PGY-2 Thrombosis and Hemostasis Management Pharmacy Residency
-
Nov 8, 2026, 05:47Safaa Hilal: POCUS in the Evaluation of Perioperative Troponin Elevation